All In MedTech

Device Trial Radar · NCT02506465

Pivotal Study to Assess the Safety and Effectiveness of the iTind Device

Multi-center Prospective Study to Assess the Safety and Effectiveness of Medi-Tate i-Temporary Implantable Nitinol Device (iTind) in Subjects With Symptomatic Benign Prostatic Hyperplasia (BPH)

Last checked: Nov 19, 2026Latest source record: Feb 28, 2022 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingTitle says "pivotal". Randomized with 185 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

185

Actual

Start

Jul 2015

Primary completion

Oct 2018

Study completion Oct 2018

Sponsor

Lead sponsor
Medi-Tate Ltd.Not on our public-company list
Sponsor type
Industry
First posted
Jul 23, 2015

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
Single (participant)
Primary purpose
Treatment
Who can join
Male only, from 50 years, up to 80 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The study objectives are to demonstrate the efficacy and safety of the Medi-Tate iTIND as compared to control group (catheter only).

Conditions

  • Benign Prostate Hyperplasia

Interventions

  • iTINDDevice

    Temporary Implantable Nitinol Device (iTIND)

  • Sham ArmProcedure

    Foley catheter will be placed and immediately removed.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Month 3 Results in the IPSS Score in Both Arms.Time frame: 3 months

Locations

13 sites in 2 countries. Site status is shown where the registry gives one.

  • Clinical Research Center of Florida

    Pompano Beach, Florida

  • Chesapeake Urology Research Associates

    Baltimore, Maryland

  • Methodist Hospital

    Brooklyn, New York

10 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.